[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-461345-105":59,"doc-detail-461345-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","endovascular-treatment-versus-vein-bypass-of-infrainguinal-peripheral-artery-disease-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials","Endovascular Treatment Versus Vein Bypass of Infrainguinal Peripheral Artery Disease - A Systematic Review and Meta-Analysis of Randomized Controlled Trials","","Guidelines recommend endovascular therapy (ET) for infrainguinal peripheral artery disease (PAD) despite limited adequately powered evidence. This systematic review and meta-analysis directly compared clinical safety and efficacy of ET versus vein bypass (VBP) using randomized controlled trials (RCTs). Searches of MEDLINE, Embase, and Cochrane databases (to 21 July 2023) pooled odds ratios (Mantel–Haenszel) and assessed risk of bias. Four low-risk-of-bias RCTs were included; ET increased reintervention and major reintervention, while no significant differences emerged for mortality and key adverse outcomes. When an appropriate vein is available, VBP should be considered primary therapy.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/endovascular-treatment-versus-vein-bypass-of-infrainguinal-peripheral-artery-disease-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials/461345/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/endovascular-treatment-versus-vein-bypass-of-infrainguinal-peripheral-artery-disease-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials/461345.png","ImageObject",300,407,{"name":92,"@type":93},"Franzy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What comparison does this systematic review evaluate for infrainguinal PAD?","Question",{"text":113,"@type":114},"It directly compares endovascular therapy (ET) versus vein bypass (VBP) in patients with infrainguinal peripheral artery disease using randomized controlled trials.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were the studies searched and selected?",{"text":118,"@type":114},"The review searched MEDLINE, Embase, and Cochrane databases from inception through 21 July 2023 for RCTs comparing ET and VBP, following PRISMA and AMSTAR guidance.",{"name":120,"@type":111,"acceptedAnswer":121},"What major outcome differences were found between ET and VBP?",{"text":122,"@type":114},"ET was associated with significantly higher risks of reintervention and major reintervention, but no significant differences were observed for 30-day mortality, all-cause mortality, major adverse cardiovascular events (MACE), limb amputation, or bleeding events.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},461345,1790815660,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Systematic Review  \nEndovascular Treatment Versus Vein Bypass of Infrainguinal Peripheral Artery Disease: A Systematic Review and  \nMeta-Analysis of Randomized Controlled Trials  \nYuhan Qi 1,2,†, Yu Yang 1,2,†, Chengxin Weng 1, Jichun Zhao 1, Jiarong Wang 1, Ding Yuan 1 and Tiehao Wang 1, *  \nAcademic Editors: Olivier Moreland Alexander Oberhuber  \nReceived: 10 November 2025  \nRevised: 13 December 2025  \nAccepted: 16 December 2025  \nPublished: 19 December 2025  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Division of Vascular Surgery, Department of General Surgery, West China Hospital, Sichuan University, 37 Guo Xue Alley, Chengdu 610041, China  \n2 West China School of Medicine, Sichuan University, Chengdu 610041, China  \n* Correspondence: [tiehao.wang@wchscu.cn](tiehao.wang@wchscu.cn); Tel.: +86-18780067714 † These authors contributed equally to this work.  \nAbstract  \nObjectives: Guidelines widely recommend endovascular therapy (ET) for infrainguinal peripheral artery diseases (PAD) despite the lack of adequately powered data. This metaanalysis aimed to directly compare the clinical safety and efficacy of ET versus vein bypass (VBP) in patients with infrainguinal PAD from available randomized controlled trials (RCTs) . Methods: We conducted a systematic literature search of MEDLINE, Embase, and the Cochrane databases from inception until 21 July 2023 for RCTs comparing ET and VBP. Treatment effects were expressed as odds ratios (OR) with 95% confidence intervals (CIs), pooled using the Mantel–Haenszel method. Study quality was assessed via the Cochrane Risk of Bias tool. Results: From 2210 identified studies, four low-risk-of-bias RCTs were included. Pooled analysis demonstrated that ET was associated with significantly higher risks of reintervention (OR = 4.69, 3.69–6.04), major reintervention (OR = 2.80, 1.96–4.00), and any reintervention (OR = 1.92, 1.44–2.56) compared to VBP. ET also showed a lower rate of index procedure technical success (OR = 0.13, 0.07–0.25) and site infection (OR = 0.05, 0.01–0.25) . However, no significant differences were observed between the two strategies regarding 30-day mortality (OR = 0.66, 0.34–1.29), all-cause mortality (HR = 1.05, 0.90–1.22), index limb amputation (OR = 1.29, 0.90–1.86), MACE (OR = 1.20, 0.94–1.54), or bleeding events (OR = 0.86, 0.30–2.50) . Conclusions: This analysis of RCT data still supports VBP, which retained certain advantages over ET for patients with infrainguinal peripheral artery disease in terms of both efficacy and safety. In cases where a suitable vein is available, vein bypass should be considered as the primary treatment option.  \nKeywords: endovascular treatment; vein bypass; infrainguinal peripheral artery disease; meta-analysis  \n1. Introduction  \nPeripheral artery disease (PAD) is a prevalent condition affecting more than 200 million people worldwide. Chronic limb-threatening ischemia (CLTI) presents as chest pain, ischemic ulcers, or gangrene in the foot and occurs in up to 11% of PAD cases [1,2] . In addition to the severe health consequences of CLTI, there is a significant economic burden, with annual costs in the United States estimated at around $12 billion [3] .  \nOver the past decades, bypass surgery (BSx) and endovascular treatment (ET) have been introduced as the mainstream treatments for PAD. However, the choice of treatment  \nfor lesions in PAD varies, and the optimal treatment approach has been a subject of ongoing controversy. In recent years, due to the increasing development of endovascular device, the Trans-Atlantic Inter-Society Consensus (TASC II), European Society of Cardiology (ESC), and European Society for Vascular Surgery (ESVS) endorse an “endovascular-first”approach for lesions shorter than 25 cm in PAD [4–6] . A previous meta-analysis also showed that ET could be an ","cbCaiv9MoIHBY3sA","https://ap.wps.com/l/cbCaiv9MoIHBY3sA","pdf",1567187,11,"English","# Abstract\n# 1. Introduction\n# 2. Methods\n## 2.1. Search Strategy and Selection Criteria","[{\"question\":\"What comparison does this systematic review evaluate for infrainguinal PAD?\",\"answer\":\"It directly compares endovascular therapy (ET) versus vein bypass (VBP) in patients with infrainguinal peripheral artery disease using randomized controlled trials.\"},{\"question\":\"How were the studies searched and selected?\",\"answer\":\"The review searched MEDLINE, Embase, and Cochrane databases from inception through 21 July 2023 for RCTs comparing ET and VBP, following PRISMA and AMSTAR guidance.\"},{\"question\":\"What major outcome differences were found between ET and VBP?\",\"answer\":\"ET was associated with significantly higher risks of reintervention and major reintervention, but no significant differences were observed for 30-day mortality, all-cause mortality, major adverse cardiovascular events (MACE), limb amputation, or bleeding events.\"}]","Endovascular Treatment Versus Vein Bypass of Infrainguinal Peripheral Artery Disease - A Systematic Review and Meta-Analysis of Randomized Controlled Trials | PDF",1790761392,28,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/280cba7ca4db03e9e85506cd4df0c787.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/5bd4afad9556c3fb5d7638cda4e9ba1f.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/64d33fbd2e7b5be93a38d53d364b4db5.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/e8dd8befa815d305f4fdf4509da1ec8e.webp",980,1385]